Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)

clinicaltrials.gov/study/NCT00354614

Is a

‌

Clinical study

Clinical Study attributes

NCT Number

NCT003546140

Health Conditions in Trial

Obstructive sleep apnea

Trial Recruitment Size

810

Trial Sponsor

ResMed

Clinical Trial Start Date

2006

Primary Completion Date

2007

Study Completion Date

2007

Clinical Trial Study Type

Observational0

Observational Clinical Trial Type

Cohort0

Observational Study Perspective

Prospective0

Participating Facility

University of Pittsburgh Medical Center

Official Name

Validation of the ApneaLink Sleep Screener in a Suspected Sleep Disordered Breathing Population0

Last Updated

June 28, 2017

Study summary

The primary endpoints for this study are that the AL validation will 1) achieve a sensitivity of greater than 80% for AHI values greater than or equal to 15, and 2) demonstrate a correlation coefficient of r=0.75 indicating strong correlation between the AHI of diagnostic PSG and AL.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)

Contents

Clinical Study attributes

Timeline

Further Resources

References

Find more entities like Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)